Bank of New York Mellon’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38M Buy
241,587
+535
+0.2% +$5.07K ﹤0.01% 2848
2026
Q1
$2.06M Buy
241,052
+9,743
+4% +$87.4K ﹤0.01% 2794
2025
Q4
$2.04M Buy
231,309
+169,126
+272% +$1.96M ﹤0.01% 2818
2025
Q3
$824K Buy
62,183
+3,608
+6% +$45.1K ﹤0.01% 3327
2025
Q2
$800K Buy
58,575
+9,587
+20% +$129K ﹤0.01% 3244
2025
Q1
$674K Buy
48,988
+23,373
+91% +$341K ﹤0.01% 3284
2024
Q4
$438K Buy
25,615
+1,941
+8% +$33.6K ﹤0.01% 3593
2024
Q3
$435K Buy
+23,674
New +$418K ﹤0.01% 3592

Other funds holding ARDT

Bank of New York Mellon's ARDT Position: Q2 2026 in Review

Bank of New York Mellon increased its Ardent Health (ARDT) stake by 0.22% in Q2 2026, buying an estimated $5.07K and bringing the position to 241,587 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2848.

Bank of New York Mellon first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. 51 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Bank of New York Mellon held 241,587 shares of Ardent Health worth $2.38M as of Q2 2026.
  • Bank of New York Mellon bought 535 Ardent Health shares in Q2 2026, an estimated $5.07K.
  • Ardent Health made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2848 holding.
  • Bank of New York Mellon first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • 51 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.